NCT04605107View on ClinicalTrials.gov

Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 30, 2013

Primary Completion Date

January 8, 2015

Study Completion Date

March 8, 2015

Conditions
Infertility, Female
Interventions
DRUG

Epifasi: Human chorionic gonadotrophin

IM Injection of 1 ampoule contains 5000 I.U. of Human chorionic gonadotrophin

DRUG

Pregnyl: Human chorionic gonadotrophin

IM Injection of 1 ampoule contains 5000 I.U. of Human chorionic gonadotrophin

Trial Locations (1)

11757

Genuine Research Center GRC, Cairo

All Listed Sponsors
collaborator

EIPICO PHARMA, EGYPT

UNKNOWN

lead

Genuine Research Center, Egypt

INDUSTRY

NCT04605107 - Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA). | Biotech Hunter | Biotech Hunter